- DePuy Synthes has obtained European CE Mark for Bi-Mentum Dual Mobility System.
- Bi-Mentum Dual Mobility System is can help patients who are higher risk of hip dislocation.
According to an announcement made by Johnson & Johnson, DePuy Synthes, which produces cement less hip implants, has obtained the European CE Mark which stands for Conformité Européenne. DePuy Synthes has obtained CE mark on its new Bi-Mentum Dual Mobility System that is useful for patients with a higher risk of hip dislocation.
Featuring a standard femoral head articulating within a large polyethylene liner, Bi-Mentum can swivel within a metal shell. The system has been designed to reduce the risk of dislocation. This gadget can impact patient satisfaction and result in later revision costs.
Need For Bi-Mentum Dual Mobility System
Since 1975, more than three million hip arthroplasties have been registered in Europe. The incidence of instability caused by dislocation after Total Hip Arthroplasty (THA) in the primary setting has been reported to be 7%. The same in revision setting has been reported to be 25%. Instability can have a significant impact on patients’ quality of life as well as mobility. It can also create the need for repeat surgeries, and thus, incur high costs in a resource-constrained environment. The surgical treatment of a dislocating THA might also raise the cost of hip replacement by 342%.
Aaron Villaruz, vice president and global platform leader for hips at Depuy Synthes, said:
“With an increasing number of patients undergoing hip replacement surgery, surgeons need to address a broader range of surgical needs to help their patients stay active and get on with their lives. Securing the CE Mark on BI-MENTUM enables us to better serve our customers and patients across Europe with a solution that is designed to make a continued difference in hip replacement.”